Corient Private Wealth’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.2K | Sell |
17,523
-1
| -0% | -$2 | ﹤0.01% | 2497 |
|
|
2025
Q1 | $46.8K | Hold |
17,524
| – | – | ﹤0.01% | 2224 |
|
|
2024
Q4 | $77.3K | Hold |
17,524
| – | – | ﹤0.01% | 2243 |
|
|
2024
Q3 | $276K | Buy |
17,524
+14,164
| +422% | +$223K | ﹤0.01% | 2023 |
|
|
2024
Q2 | $91.2K | Hold |
3,360
| – | – | ﹤0.01% | 2213 |
|
|
2024
Q1 | $120K | Hold |
3,360
| – | – | ﹤0.01% | 2157 |
|
|
2023
Q4 | $90.2K | Sell |
3,360
-61
| -2% | -$1.64K | ﹤0.01% | 2163 |
|
|
2023
Q3 | $116K | Sell |
3,421
-597
| -15% | -$20.2K | ﹤0.01% | 1999 |
|
|
2023
Q2 | $134K | Sell |
4,018
-61
| -1% | -$2.03K | ﹤0.01% | 1930 |
|
|
2023
Q1 | $214K | Hold |
4,079
| – | – | ﹤0.01% | 1758 |
|
|
2022
Q4 | $197K | Buy |
+4,079
| New | +$197K | ﹤0.01% | 1493 |
|